Funding for this research was provided by:
Bristol-Myers Squibb
Article History
Received: 21 January 2019
Accepted: 23 February 2019
First Online: 22 March 2019
Compliance with ethical standards
:
: M Provencio has served as consultant or advisor for Bristol-Myers Squibb, Celgene, Merck Sharp and Dohme, Pierre Fabre, and Roche. E. Carcereny has served as consultant or advisor for Bristol-Myers Squibb, Merck, Pfizer, and Roche; and has received travel and expenses funding from Bristol-Myers Squibb, and Pfizer. Á. Artal has participated on the speaker´s bureau and advisory boards for Bristol-Myers Squibb, Merck Sharp and Dohme, and Roche-Genentech; and has received travel and expenses funding form Bristol-Myers Squibb and Roche.
: This article does not contain any studies with human participants performed by any of the authors.
: This article does not contain any studies with human participants performed by any of the authors, so informed consent was not required.